NM

R New Jersey General Assembly · District 21 · Former member

Asm. Nancy Muñoz

Contact Email Phone Official site ↗

Compare

Total votes

5,751

all sessions

Attendance

94%

278 missed

Near the chamber average

With party

96%

of cast votes

Lower than 82% of chamber peers

Bipartisan score

3%

crosses aisle rarely

Higher than 82% of chamber peers

Voting record

Yea

4,550

voted in favor

Nay

743

voted against

Absent

278

missed votes

Total cast

5,751

across all sessions

Crossed party

197

votes against own party

This page

5,751

matching current filters

Bill

Description

Vote

Result

Tally

Date

A 2995

Establishes central registry for sickle cell trait diagnoses; provides for informational outreach and genetic counseling.

Yea

Passed

9–0

Oct 6, 2016

A 3631

Permits holding companies of eligible New Jersey emerging technology companies to receive investments under "New Jersey Angel Investor Tax Credit Act."

Yea

Passed

11–0

Oct 6, 2016

S 2477

Concerns certain unused portions of tax credits issued to insurance premiums taxpayers under the Business Employment Incentive Program; exempts certain purchasers of business development incentives from certain State tax notification requirements.*

Yea

Passed

11–0

Oct 6, 2016

A 4189

Extends duration of first five designated UEZs for two additional years; specifies permissible use of UEZ funds; requires DCA Commissioner to assess and issue report on UEZ program.

Other

Passed

9–1

Oct 6, 2016

A 3969

Requires DOH to establish Zika Virus State Action Plan.

Yea

Passed

10–0

Oct 6, 2016

A 2183

Requires county health departments to maintain reserve stock of opioid antidotes to dispense to certain entities on interim basis to ensure uninterrupted supply.*

Yea

Passed

10–0

Oct 6, 2016

A 2993

Requires Medicaid coverage for diabetes self-management education, training, services, and equipment for patients diagnosed with diabetes, gestational diabetes, and pre-diabetes.

Yea

Passed

10–0

Oct 6, 2016

S 158

Permits holding companies of eligible New Jersey emerging technology companies to receive investments under "New Jersey Angel Investor Tax Credit Act."

Yea

Passed

11–0

Oct 6, 2016

A 3793

Clarifies that product approval from U.S. Food and Drug Administration is not required for drug manufacturer to file registration statement, and specifies timeframe by which DOH must review registration statements.

Yea

Passed

10–0

Oct 6, 2016

A 4094

Requires epinephrine auto-injectors to be packaged and sold as single units.

Yea

Passed

10–0

Oct 6, 2016